Kim S C, Min Y H, Lee S, Chung S Y, Yoo N C, Lee J W, Hahn J S, Ko Y W
Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Korean J Intern Med. 1998 Feb;13(1):41-6. doi: 10.3904/kjim.1998.13.1.41.
To quantitate apoptosis and Fas antigen expression of T lymphocytes by activation in aplastic anemia (AA) and compare with that of normal controls and completely-recovered AA, and to investigate the apoptotic sensitivity to anti-fas antibody of activated T lymphocytes in AA.
We studied the expression of Fas antigen on fresh T lymphocytes of twenty patients with AA [13 newly diagnosed, 7 recorvered AA after immunosuppressive therapy (IST)], and investigated the activation-induced cell death (AICD) and Fas expression by activation [interleukin-2 (200 U/ml) and phytohemagglutinin (50 micrograms/ml)] in 5 newly-diagnosed AA, 5 normal controls and 5 AA in complete response (CR). Apoptotic sensitivity to anti-Fas antibody was assessed by the time-course kinetics of induction of cell death by anti-Fas antibody (500 ng/ml).
There was no significant difference of Fas antigen expression on freshly-isolated T lymphocytes among newly-diagnosed severe AA, normal controls and patients with AA in CR after IST. In normal controls, T lymphocytes death was greatly increased at 3 days of activation, and Fas antigen expression on T lymphocytes was increased above baseline at day 1 of activation. In contrast, in newly-diagnosed AA, T lymphocytes showed delayed cell death, which correlated with a slowed increase of Fas antigen expression by activation. Also, anti-Fas antibody sensitivity of activated T lymphocytes was decreased in newly-diagnosed AA. In completely recovered AA, these abnormal AICD and Fas antigen expressions by activation were recovered to normal range.
Abnormal AICD plays a role in the immune pathophysiology of AA, and defective Fas system is involved in this process.
定量分析再生障碍性贫血(AA)中活化T淋巴细胞的凋亡及Fas抗原表达,并与正常对照及完全缓解的AA患者进行比较,研究AA中活化T淋巴细胞对抗Fas抗体的凋亡敏感性。
我们研究了20例AA患者[13例新诊断患者,7例免疫抑制治疗(IST)后缓解的AA患者]新鲜T淋巴细胞上Fas抗原的表达,并在5例新诊断的AA患者、5例正常对照和5例完全缓解(CR)的AA患者中,通过活化[白细胞介素-2(200 U/ml)和植物血凝素(50μg/ml)]研究活化诱导的细胞死亡(AICD)和Fas表达。通过抗Fas抗体(500 ng/ml)诱导细胞死亡的时间进程动力学评估对抗Fas抗体的凋亡敏感性。
新诊断的重型AA患者、正常对照和IST后CR的AA患者新鲜分离的T淋巴细胞上Fas抗原表达无显著差异。在正常对照中,活化3天时T淋巴细胞死亡显著增加,活化第1天时T淋巴细胞上Fas抗原表达高于基线水平。相反,在新诊断的AA患者中,T淋巴细胞显示细胞死亡延迟,这与活化后Fas抗原表达增加缓慢相关。此外,新诊断的AA患者中活化T淋巴细胞对抗Fas抗体的敏感性降低。在完全缓解的AA患者中,这些异常的活化诱导的AICD和Fas抗原表达恢复到正常范围。
异常的AICD在AA的免疫病理生理过程中起作用,Fas系统缺陷参与了这一过程。